Medicenna Therapeutics Stock Forecast

TSX-MDNA's stock price has decreased by -54.84% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 4 analysts polled by S&P Global, Medicenna Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $3.88. The average 1-year stock price forecast is 812.94% higher than the current stock price, while the lowest is $3.75 (+782.35%) and the highest is $4.00 (+841.18%).

Price Target: $3.88 (+812.94%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$3.75	$3.88	$3.88	$4.00
Change	+782.35%	+812.94%	+812.94%	+841.18%

* Price targets were last updated on Dec 11, 2025.

Analyst Ratings

The average analyst rating for Medicenna Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Apr '26
Strong Buy	4	4	4	4	4	4
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Martin PhD Bloom Burton	Bloom Burton	Buy Maintains $4.00	Buy	Maintains	$4.00	+841.18%	Dec 11, 2025

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

896.00K

EPS This Year

-0.55

EPS Next Year

0.60

from -0.55

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Mar 31, 2021	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026
Revenue	-	-	-	-	-	-
Operating Income	-17.40M	-22.47M	-16.30M	-18.67M	-20.41M	-22.67M
Net Income	-17.29M	-22.58M	-10.05M	-25.47M	-11.81M	-19.70M
EPS	-	-	-	-	-	-0.55
Free Cash Flow	-9.15M	-15.14M	-4.41M	-13.86M	-10.24M	-27.60M
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CAD.

Revenue Forecast

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.55
Low	-

EPS Growth

EPS Growth	2027	2028
High	-
Avg	-
Low	-